Johan Sebti
YOU?
Author Swipe
View article: Panorama des pathologies infectieuses et non infectieuses de Polynésie française en 2025
Panorama des pathologies infectieuses et non infectieuses de Polynésie française en 2025 Open
Overview of infectious and non-infectious diseases in French Polynesia in 2025 Tahiti or the “myth of Paradise”, Bora Bora, “the Pearl of the Pacific”. Who has never wanted to take a plane and come and land on the heavenly beaches of Polyn…
View article: Suicide attempts in French Polynesia during the era of COVID-19: a prospective analysis over three years
Suicide attempts in French Polynesia during the era of COVID-19: a prospective analysis over three years Open
The study is investigator-initiated without funding.
View article: Artificial intelligence and suicide prevention: A systematic review
Artificial intelligence and suicide prevention: A systematic review Open
Background Suicide is one of the main preventable causes of death. Artificial intelligence (AI) could improve methods for assessing suicide risk. The objective of this review is to assess the potential of AI in identifying patients who are…
View article: Suicide in French Polynesia: a retrospective analysis based on medicolegal documents and interview with family
Suicide in French Polynesia: a retrospective analysis based on medicolegal documents and interview with family Open
Objective To analyse the epidemiological data on suicide in French Polynesia (FP). Methods Data on suicides were collected from the Public Health Direction, Judicial Police Investigations Court of Justice records, the Centre d’Opérations e…
View article: Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer’s disease: A post-mortem study with PET radiopharmaceuticals
Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer’s disease: A post-mortem study with PET radiopharmaceuticals Open
PET imaging studies using 5-HT1A receptor radiotracers show a decreased density of this receptor in hippocampi of patients with Alzheimer's disease (AD) at advanced stages. However, current 5-HT1A receptor radiopharmaceuticals used in neur…